Waltham, MA – Jan. 13, 2025 – Scipher Medicine, a leader in precision medicine for autoimmune diseases, and Roivant, a global biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that...
The partnership integrates transcriptome genomic data from Scipher’s PrismRA Test into OMNY’s EMR network, unlocking deeper patient insights for precision medicine advancements. Atlanta, Georgia – Jan. 9, 2025 – OMNY Health, the leading healthcare...
WALTHAM, Mass., December 18, 2024 Scipher Medicine, a leader in precision medicine for autoimmune diseases, and Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence, today announced a strategic partnership to...
WALTHAM, Mass., July 30, 2024 Scipher Medicine, a company focused on proprietary AI and network biology platform solutions to transform patient care, has launched a new approach to develop biomarkers following the publication of the novel, patent-pending...
WALTHAM, Mass., June 13, 2024 Scipher Medicine, a company focused on proprietary AI and network biology platform solutions to transform patient care, is attending and presenting at the annual European Alliance of Associations for Rheumatology (EULAR) conference in...
WALTHAM, Mass., May 9, 2024 Scipher Medicine, an AI-enabled precision immunology company, today announced the appointment of Reginald Seeto, MBBS*, as Chief Executive Officer and President. Scipher developed SpectraTM, a proprietary AI platform that has been...
